After first dose of Pfizer vaccine, antibody, but not T-cell response, is weakened in patients receiving methotrexate
A new study presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, shows that the antibody—but not the T-cell—response to the first ...
Jul 9, 2021
0
2